<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In this study, we investigated whether <z:chebi fb="0" ids="27881">resveratrol</z:chebi> could protect against ischemic injury by improving brain energy metabolism and alleviating <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Male rats were divided into three groups: sham operation, <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> treatment, and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> combined with <z:chebi fb="0" ids="27881">resveratrol</z:chebi> treatment (<z:chebi fb="0" ids="27881">resveratrol</z:chebi>-treated group, 30 mg/kg intraperitoneally for 7 days) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo> was induced by using the model of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The dialysates in hypothalamus were obtained by brain microdialysis technique </plain></SENT>
<SENT sid="4" pm="."><plain>The effects of <z:chebi fb="0" ids="27881">resveratrol</z:chebi> on neurologic functions and histopathologic changes were evaluated </plain></SENT>
<SENT sid="5" pm="."><plain>The levels of ATP, <z:chebi fb="13" ids="16761">ADP</z:chebi>, <z:chebi fb="47" ids="16027,28971">AMP</z:chebi>, <z:chebi fb="3" ids="16335">adenosine</z:chebi>, <z:chebi fb="0" ids="17596">inosine</z:chebi>, <z:chebi fb="0" ids="17368">hypoxanthine</z:chebi> and <z:chebi fb="1" ids="15318,17712">xanthine</z:chebi> in microdialysate were monitored by HPLC analysis </plain></SENT>
<SENT sid="6" pm="."><plain>The levels of malondialdehyde and the activities of <z:chebi fb="1" ids="15318,17712">xanthine</z:chebi> oxidase in brain tissues were analyzed in three groups </plain></SENT>
<SENT sid="7" pm="."><plain>This study shows that the ischemic <z:mpath ids='MPATH_124'>infarcts</z:mpath> were significantly reduced and neurological functions were improved in <z:chebi fb="0" ids="27881">resveratrol</z:chebi>-treated group compared to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> group </plain></SENT>
<SENT sid="8" pm="."><plain>The analysis results show that <z:chebi fb="0" ids="27881">resveratrol</z:chebi> treatments remarkably enhanced the level of <z:chebi fb="105" ids="17234">glucose</z:chebi>, ATP and energy charge; decreased the levels of <z:chebi fb="4" ids="24996">lactate</z:chebi> during I/R period </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="27881">Resveratrol</z:chebi> treatments significantly increased the basal levels of adesonine and <z:chebi fb="0" ids="17596">inosine</z:chebi>, inhibited the elevations of <z:chebi fb="0" ids="17368">hypoxanthine</z:chebi> and <z:chebi fb="1" ids="15318,17712">xanthine</z:chebi> levels and remarkably decreased <z:chebi fb="1" ids="15318,17712">xanthine</z:chebi> oxidase activity and malondialdehyde levels </plain></SENT>
<SENT sid="10" pm="."><plain>This study provides in vivo evidence that <z:chebi fb="0" ids="27881">resveratrol</z:chebi> could exert neuroprotective effect against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> injury by improving brain energy metabolism and alleviating <z:mp ids='MP_0003674'>oxidative stress</z:mp> via inhibiting <z:chebi fb="1" ids="15318,17712">xanthine</z:chebi> oxidase activity and preventing the production of <z:chebi fb="0" ids="17368">hypoxanthine</z:chebi>, <z:chebi fb="1" ids="15318,17712">xanthine</z:chebi> and oxygen radicals during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion </plain></SENT>
</text></document>